TrialJournal of comparative effectiveness research2025

Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.

Sarah Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.